Human monoclonal antibody against colon cancer

Chong Zheng Yao, Jin Ishizuka, Richard J. Bold, Howard E. Sperling, Courtney Townsend, James C. Thompson

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The purpose of the study was to produce human monoclonal antibodies (hMcAb) against human colon cancer for use in radioimmunoimaging. Human-mouse heterohybridomas were developed by fusing SHM-D33 mouse-human hybrid heteromyeloma cells with human lymphocytes from colon cancer tumor-draining lymph nodes. The hybridomas capable of secreting human monoclonal antibodies were screened by using human colon cancer cell fines and pathological biopsies with ELISA and immunohistochemical methods. hMcAb clone H11 was selected for a large-scale antibody production, which was purified from mouse ascites. Biodistribution study demonstrated that specific uptake of 125I-hMcAb H11 by human colon cancer xenografts was significantly higher than by normal tissues. Radioimmunoimaging of human colon cancer xenografts exhibited distinct tumor visualization during the period of 72-96 hr after intraperitoneal injection of 125I-hMcAb H11. The development of human monoclonal antibodies such as hMcAb H11 may be useful for radioimmunodetection and therapy of colon cancer.

Original languageEnglish (US)
Pages (from-to)211-217
Number of pages7
JournalCancer Investigation
Volume14
Issue number3
StatePublished - 1996

Fingerprint

Colonic Neoplasms
Monoclonal Antibodies
Radioimmunodetection
Heterografts
Hybrid Cells
Hybridomas
Human Development
Intraperitoneal Injections
Ascites
Antibody Formation
Neoplasms
Clone Cells
Lymph Nodes
Enzyme-Linked Immunosorbent Assay
Lymphocytes
Biopsy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Yao, C. Z., Ishizuka, J., Bold, R. J., Sperling, H. E., Townsend, C., & Thompson, J. C. (1996). Human monoclonal antibody against colon cancer. Cancer Investigation, 14(3), 211-217.

Human monoclonal antibody against colon cancer. / Yao, Chong Zheng; Ishizuka, Jin; Bold, Richard J.; Sperling, Howard E.; Townsend, Courtney; Thompson, James C.

In: Cancer Investigation, Vol. 14, No. 3, 1996, p. 211-217.

Research output: Contribution to journalArticle

Yao, CZ, Ishizuka, J, Bold, RJ, Sperling, HE, Townsend, C & Thompson, JC 1996, 'Human monoclonal antibody against colon cancer', Cancer Investigation, vol. 14, no. 3, pp. 211-217.
Yao CZ, Ishizuka J, Bold RJ, Sperling HE, Townsend C, Thompson JC. Human monoclonal antibody against colon cancer. Cancer Investigation. 1996;14(3):211-217.
Yao, Chong Zheng ; Ishizuka, Jin ; Bold, Richard J. ; Sperling, Howard E. ; Townsend, Courtney ; Thompson, James C. / Human monoclonal antibody against colon cancer. In: Cancer Investigation. 1996 ; Vol. 14, No. 3. pp. 211-217.
@article{bd8ad4ab5bdb499896c268f7e20cfc13,
title = "Human monoclonal antibody against colon cancer",
abstract = "The purpose of the study was to produce human monoclonal antibodies (hMcAb) against human colon cancer for use in radioimmunoimaging. Human-mouse heterohybridomas were developed by fusing SHM-D33 mouse-human hybrid heteromyeloma cells with human lymphocytes from colon cancer tumor-draining lymph nodes. The hybridomas capable of secreting human monoclonal antibodies were screened by using human colon cancer cell fines and pathological biopsies with ELISA and immunohistochemical methods. hMcAb clone H11 was selected for a large-scale antibody production, which was purified from mouse ascites. Biodistribution study demonstrated that specific uptake of 125I-hMcAb H11 by human colon cancer xenografts was significantly higher than by normal tissues. Radioimmunoimaging of human colon cancer xenografts exhibited distinct tumor visualization during the period of 72-96 hr after intraperitoneal injection of 125I-hMcAb H11. The development of human monoclonal antibodies such as hMcAb H11 may be useful for radioimmunodetection and therapy of colon cancer.",
author = "Yao, {Chong Zheng} and Jin Ishizuka and Bold, {Richard J.} and Sperling, {Howard E.} and Courtney Townsend and Thompson, {James C.}",
year = "1996",
language = "English (US)",
volume = "14",
pages = "211--217",
journal = "Cancer Investigation",
issn = "0735-7907",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Human monoclonal antibody against colon cancer

AU - Yao, Chong Zheng

AU - Ishizuka, Jin

AU - Bold, Richard J.

AU - Sperling, Howard E.

AU - Townsend, Courtney

AU - Thompson, James C.

PY - 1996

Y1 - 1996

N2 - The purpose of the study was to produce human monoclonal antibodies (hMcAb) against human colon cancer for use in radioimmunoimaging. Human-mouse heterohybridomas were developed by fusing SHM-D33 mouse-human hybrid heteromyeloma cells with human lymphocytes from colon cancer tumor-draining lymph nodes. The hybridomas capable of secreting human monoclonal antibodies were screened by using human colon cancer cell fines and pathological biopsies with ELISA and immunohistochemical methods. hMcAb clone H11 was selected for a large-scale antibody production, which was purified from mouse ascites. Biodistribution study demonstrated that specific uptake of 125I-hMcAb H11 by human colon cancer xenografts was significantly higher than by normal tissues. Radioimmunoimaging of human colon cancer xenografts exhibited distinct tumor visualization during the period of 72-96 hr after intraperitoneal injection of 125I-hMcAb H11. The development of human monoclonal antibodies such as hMcAb H11 may be useful for radioimmunodetection and therapy of colon cancer.

AB - The purpose of the study was to produce human monoclonal antibodies (hMcAb) against human colon cancer for use in radioimmunoimaging. Human-mouse heterohybridomas were developed by fusing SHM-D33 mouse-human hybrid heteromyeloma cells with human lymphocytes from colon cancer tumor-draining lymph nodes. The hybridomas capable of secreting human monoclonal antibodies were screened by using human colon cancer cell fines and pathological biopsies with ELISA and immunohistochemical methods. hMcAb clone H11 was selected for a large-scale antibody production, which was purified from mouse ascites. Biodistribution study demonstrated that specific uptake of 125I-hMcAb H11 by human colon cancer xenografts was significantly higher than by normal tissues. Radioimmunoimaging of human colon cancer xenografts exhibited distinct tumor visualization during the period of 72-96 hr after intraperitoneal injection of 125I-hMcAb H11. The development of human monoclonal antibodies such as hMcAb H11 may be useful for radioimmunodetection and therapy of colon cancer.

UR - http://www.scopus.com/inward/record.url?scp=0029784460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029784460&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 211

EP - 217

JO - Cancer Investigation

JF - Cancer Investigation

SN - 0735-7907

IS - 3

ER -